Product
AG-01
1 clinical trial
4 indications
Indication
Triple-Negative Breast CancerIndication
Breast CancerIndication
Lung CancerIndication
MesotheliomaClinical trial
FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and MesotheliomaStatus: Recruiting, Estimated PCD: 2026-06-01